Anti-Fibrotic Therapy

Cambridge, Massachusetts, U.S., September 23, 2026 Flagship Pioneering has secured a first-of-its-kind contract worth up to $47 million over...

Toronto, Ontario, Canada, September 23, 2026 Cardiol Therapeutics has announced that its pivotal Phase III MAVERIC clinical trial evaluating...

ANTWERP, Belgium — September 14, 2026 Agomab Therapeutics NV announced positive Phase 1 results for AGMB-447, an investigational inhaled,...

NANTONG, China, July 31, 2026 Ractigen Therapeutics has received U.S. Food and Drug Administration (FDA) clearance of its Investigational...

BOSTON, Mass. | June 23, 2026 Mediar Therapeutics has announced that the first cohorts have been dosed in its...

SHANGHAI, Feb. 12, 2026 — AGCO Biomedical Technology Co., Ltd. announced that the U.S. Food and Drug Administration (FDA)...